EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Intra-tumor DKK1 and CALML5 heterogeneity as a novel biomarker for prognosis and immunotherapy response in head and neck squamous cell carcinoma

Yuhui Li, Rongxi Chen, Lizao Zhang, Yanping Jiang, Siqi Ren, Songjiu Li, Hongfeng Xu, Yongmei Tan, Suling Chen, Xiao Tan, Lianxi Mai, Guoxin Huang und 16 weitere

Current Molecular Pharmacology · 2025 · 18 (1) · 6-21

DOI: 10.1016/j.cmp.2025.06.002 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Current Molecular Pharmacology, 2025. Verfasst von Yuhui Li und 27 weiteren Autor:innen. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Postdoctoral Research Foundation of China, Basic and Applied Basic Research Foundation of Guangdong Province, Guangdong Provincial Applied Science and Technology Research and Development Program.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Förderung

  • Postdoctoral Research Foundation of China
  • Basic and Applied Basic Research Foundation of Guangdong Province
  • Guangdong Provincial Applied Science and Technology Research and Development Program
  • China Postdoctoral Science Foundation
  • Shanghai Science and Technology Development Foundation
  • National Natural Science Foundation of China

Zitieren

APA

Li, Y., Chen, R., Zhang, L., Jiang, Y., Ren, S., Li, S., Xu, H., Tan, Y., Chen, S., Tan, X., Mai, L., Huang, G., Wu, F., Liu, X., Liang, P., Kuang, S., Wang, L., Liu, J., Li, J., …, & Li, J. (2025). Intra-tumor DKK1 and CALML5 heterogeneity as a novel biomarker for prognosis and immunotherapy response in head and neck squamous cell carcinoma. Current Molecular Pharmacology, 18(1), 6-21. https://doi.org/10.1016/j.cmp.2025.06.002

Vancouver

Li Y, Chen R, Zhang L, Jiang Y, Ren S, Li S, et al. Intra-tumor DKK1 and CALML5 heterogeneity as a novel biomarker for prognosis and immunotherapy response in head and neck squamous cell carcinoma. Current Molecular Pharmacology. 2025;18(1):6-21. doi:10.1016/j.cmp.2025.06.002

BibTeX
@article{Li2025,
  author = {Li, Yuhui and Chen, Rongxi and Zhang, Lizao and Jiang, Yanping and Ren, Siqi and Li, Songjiu and Xu, Hongfeng and Tan, Yongmei and Chen, Suling and Tan, Xiao and Mai, Lianxi and Huang, Guoxin and Wu, Fan and Liu, Xin and Liang, Peisheng and Kuang, Shijia and Wang, Liansheng and Liu, Jingkang and Li, Jintao and Li, Yanyan and Xu, Qiuping and Su, Ziyao and Huang, Zijing and Li, Qunxing and Lan, Tianjun and Cao, Haotian and Wu, Huiqian and Li, Jinsong},
  title = {Intra-tumor DKK1 and CALML5 heterogeneity as a novel biomarker for prognosis and immunotherapy response in head and neck squamous cell carcinoma},
  journal = {Current Molecular Pharmacology},
  year = {2025},
  volume = {18},
  number = {1},
  pages = {6--21},
  doi = {10.1016/j.cmp.2025.06.002}
}
Kostenlos starten →